Press release
North American Market for CTC Diagnostics Accounts for Nearly One-Third Revenue Share of the Global Market – Fact.MR Study
Circulating tumor cells (CTCs) are today a hot pursuit in the area of cancer research, diagnostics, and treatment as their self-renewal capabilities are one of the primary causes of tumorigenesis. The use of CTC diagnostic tests is picking pace owing to their accuracy and reliability in identifying the risks of cancer as well as in monitoring various cancer treatments.Furthermore, a mounting number of end users including hospitals, diagnostic centers, research and academic institutes, and oncology labs, are aiming to collaborate with manufacturers in the CTC diagnostics to ensure the availability of high-tech and next-generation cancer diagnostic tools and equipment for improved patient outcomes.
This is one of the most important factors that are providing an impetus to the impressive growth of the global circulating tumor cells market.
To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=5510
The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of CTC Diagnostics market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of CTC Diagnostics
The report offers actionable and valuable market insights of CTC Diagnostics. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of CTC Diagnostics Market across various industries and regions
Circulating tumor cells (CTCs) are today a hot pursuit in the area of cancer research, diagnostics, and treatment as their self-renewal capabilities are one of the primary causes of tumorigenesis. The use of CTC diagnostic tests is picking pace owing to their accuracy and reliability in identifying the risks of cancer as well as in monitoring various cancer treatments.
Why Demand for Diagnostic Kits and Reagents is Key?
The CTC diagnostics market is witnessing impressive growth with the rising demand for these diagnostic devices across various cancer research and diagnosis centers.
While the adoption of CTC diagnostic devices and systems is most common across end users, the demand for diagnostic kits and reagents is expected to pick pace in the coming years.
The convenience of using CTC testing kits and reagents along with their performance in such diagnostic procedures is one of the primary factors that are triggering the shift from diagnostic devices and systems. This trend in the CTC diagnostics market is expected to remain popular in the coming years.
Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=5510
CTC Diagnostics Market: Segmentation
The study offers a detailed estimation and outlook of the CTC diagnostics market based on the product, technology, application, sample type, and region.
Product
• Devices & Systems
• Kits & Reagents
• Other Consumables
Technology
• CTC Enrichment Methods
• CTC Detection Methods
• CTC Analysis
Application
• Cancer Stem Cell Research
• EMT Biomarkers Development
• Tumorigenesis Research
• Others
Sample Type
• Blood
• Bone Marrow
• Others
Region
• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa
What are the Key Strategies of Circulating Tumor Cells Market Players
Key players in the CTC diagnostics market include
• Qiagen
• Bio-Techne Corporation
• Janssen Diagnostics LLC
• Advanced cell Diagnostics Inc
• ApoCell Inc
• Celltraffix Inc.
• Aviva Biosciences
• Biocept Inc
• Clearbridge Biomedics
• Fluxion Biosciences
• IVDiagnostics
• Stemcell Technologies Inc
• Stemcell Technologies Inc.
• Sysmex Corporation. Leading
Leading market players are increasing their focus on research and development as innovation remains an integral part of their business strategy to gain an edge in this landscape.
Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/5510
Key Takeaways from CTC Diagnostics Market Report
• The CTC diagnostics market has surpassed the mark of US$ 6 billion, as it reached the valuation of US$ 6.3 billion in 2020. The primary factor to drive the market remains the ongoing research in the field of cancer diagnostics and alarmingly increasing number of cancer deaths around the world.
• The market is expected to witness exponential growth in the coming decade as the projected CAGR is likely to exceed beyond 17% during the forecast period of 2020 to 2030.
• The adoption of CTC enrichment methods is likely to remain significantly high, as the segment is projected to reach the valuation of over US$ 9.5 billion by the end of the assessment period.
• The North American market for CTC diagnostics is expected to lead the regional category with a valuation of over US$ 2 billion in 2020. With the ongoing cancer research in the region and growing presence of market leaders, the regional market is expected to secure one-third revenue share in the global space.
• Patients’ inclination towards non-invasive diagnostics tests and prognostic tools for predicting or detecting the risks of cancer is one of the driving forces for the growth of the market. Manufacturers are also expected to experiment around technologies for detection and analyzing CTCs to improve accuracy and reliability of results.
Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:
Fluoro Enzymatic Assays Market – https://www.factmr.com/report/fluoro-enzymatic-assays-market
Shower Chairs Market – https://www.factmr.com/report/shower-chairs-market
Infrared Thermometer Market – https://www.factmr.com/report/infrared-thermometer-market
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release North American Market for CTC Diagnostics Accounts for Nearly One-Third Revenue Share of the Global Market – Fact.MR Study here
News-ID: 2534119 • Views: …
More Releases from Fact.MR
USA Demand for Microbiome Skincare Products in USA Outlook 2025-2035: Key Develo …
The U.S. microbiome skincare market is projected to experience rapid, data-driven growth over the next decade, driven by rising consumer awareness, ingredient innovation, and the integration of personalized diagnostics. Analysts estimate the U.S. microbiome skincare segment at approximately USD 0.13 billion in 2025, with a projected increase to USD 0.35 billion by 2035, representing a compound annual growth rate (CAGR) of 10.4%.
To access the complete data tables and in-depth insights,…
USA Demand for Lubricants in USA Outlook 2025-2035: Key Developments and Future …
The U.S. lubricants market is projected to experience steady growth through 2035, driven by shifts in mobility, industrial demand, and sustainability trends. The market was valued at approximately $41.2 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 2.5%, reaching $52 billion by 2035.
To access the complete data tables and in-depth insights, request a Discount On The Report here: https://www.factmr.com/connectus/sample?flag=S&rep_id=12463
…
European Demand for Intermodal Freight Transportation in UK Outlook 2025-2035: K …
"Demand for intermodal freight transport connecting the UK and continental Europe is projected to grow at a CAGR of 6.8% between 2025 and 2035, driven by rising trade volumes, decarbonization mandates, and digital logistics innovations. The intermodal market, encompassing rail, short-sea shipping, and last-mile road delivery, is expected to handle over 18 million TEUs (twenty-foot equivalent units) annually by 2035, up from 10.2 million TEUs in 2025.
To access the complete…
USA Demand for Hydroxyapatite in USA Outlook 2025-2035: Key Developments and Fut …
The United States hydroxyapatite (HAp) market is projected to experience sustained, data-driven growth from 2025 through 2035, fueled by rising clinical demand, technological innovation, and expanded applications in regenerative medicine. Market modeling indicates that U.S. consumption of hydroxyapatite will nearly double over the next decade, with strong adoption in orthopedic, dental, and advanced biomaterial sectors.
To access the complete data tables and in-depth insights, request a Discount On The Report here:…
More Releases for CTC
Circulating Tumor Cell (CTC) Market Future Prediction Report By 2028
A new market study report by The Insight Partners on the Circulating Tumor Cell (CTC) Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period.
Get PDF Sample…
Circulating Tumor Cell (CTC) Market Future Prediction Report By 2028
Circulating Tumor Cell (CTC) Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the…
Circulating Tumor Cells (CTC) Market - Industry Trends and Forecast
The Circulating Tumor Cells (CTC) market is expanding rapidly, driven by increasing interest in liquid biopsy technologies, advancements in cancer diagnostics, and the growing prevalence of cancer globally. Circulating Tumor Cells are cancer cells that break away from the primary tumor and circulate in the bloodstream, potentially leading to the development of secondary tumors (metastasis). CTCs offer a non-invasive method to monitor cancer progression, assess treatment efficacy, and detect early…
Circulating Tumor Cell (CTC) Market Future Prediction Report By 2028
The Circulating Tumor Cell (CTC) Market business intelligence report by "The Insight Partners" entails detailed information regarding the dynamics affecting market valuation over the analysis period. It also covers the competitive landscape, market scope, and market segmentation.
Get PDF Sample Report + All Related Table and Graphs @: https://www.theinsightpartners.com/sample/TIPRE00026639/?utm_source=OpenPR&utm_medium=10852
The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological,…
Circulating Tumor Cells (CTC) Market by Technology (CTC Analysis, CTC Enrichment …
The Circulating Tumor Cells (CTC) Market is expected to gain considerable market share by 2025, while registering itself at a significant compound annual growth rate (CAGR) during the forecast period. Circulating tumor cells are essentially helpful in deciding the status of disease progression rate and projection of treatment required for the elimination of the tumor. Further advancement of different tumor markers that can be useful alongside diagnostics to monitor or…
Circulating Tumor Cells (CTC) Market Demands with Major Newest Innovations: CTC …
Circulating Tumor Cells (CTC) Market By Technology (CTC Analysis, CTC Enrichment and CTC Detection), By Application (EMT biomarkers development, Tumorigenesis research, Cancer stem cell research and others) - Global Industry Analysis & Forecast to 2025.
Competitive Insights:
The major players in the market are Biocept, ScreenCell, Biofluidica Inc, Fluxion Biosciences, Advanced Cell Diagnostics, Greiner Bio-One, Aviva Biosciences, Epic Sciences, Janssen Diagnostics, Clearbridge BioMedics Pte Ltd and CellTraffix Inc. The major players in…
